The nation of Zimbabwe has rejected a significant American health deal valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' insistence on sensitive information.
This move was revealed following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".
A government spokesman has since stated that the United States was demanding access to health data for scientific study and profit but was unwilling to share the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for more dialogue to secure a deal suitable to all parties so the nation's vital HIV programme can continue.
Wider Background
This development follows a comparable situation in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
After returning to office last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost openness and accountability.
According to reports, 16 nations in Africa have so far signed similar health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Deal
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"Put simply, our nation would provide the basic resources for scientific discovery with no certainty that the end products would be available to our population if a new health crisis emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending frameworks already set up via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This framework is designed to guarantee that when a country contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome continued dialogue with our US partners on how subsequent collaboration could be designed in a manner that honours the independence and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but recommended that negotiations should continue given that a large portion of the nation's HIV programmes were funded by external financing.
"Where specific concerns arise, such as those relating to information security or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," it added.
This impasse highlights the complex debate between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.